The global Ocular Pain Market in 2026 is seeing a significant rise in clinical attention. Long dismissed as a secondary symptom of other conditions, ocular pain is now recognized as a distinct therapeutic target, particularly as digital device usage and aging populations drive an increase in chronic eye discomfort. https://livepositively.com/unlocking-value-pricing-regulatory-landscape-and-future-forecast-for-the-ocular-bromfenac-market-2025-2032/